Current and historical daily PE Ratio for U2Bio Co Ltd (
) from 2015 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. U2Bio stock (XKRX:221800) PE ratio as of Jun 20 2024 is 59.05.
More Details
U2Bio Co Ltd (XKRX:221800) PE Ratio (TTM) Chart
U2Bio Co Ltd (XKRX:221800) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1157
- 1
- 2
- 3
- 4
- 5
- 6
- 13
U2Bio PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-20 | 59.0 | 2024-04-12 | 64.5 |
2024-06-19 | 60.3 | 2024-04-11 | 59.4 |
2024-06-18 | 61.9 | 2024-04-09 | 61.1 |
2024-06-17 | 62.7 | 2024-04-08 | 66.4 |
2024-06-14 | 66.3 | 2024-04-05 | 68.1 |
2024-06-13 | 66.6 | 2024-04-04 | 67.3 |
2024-06-12 | 66.6 | 2024-04-03 | 67.0 |
2024-06-11 | 67.5 | 2024-04-02 | 66.7 |
2024-06-10 | 67.4 | 2024-04-01 | 68.6 |
2024-06-07 | 67.4 | 2024-03-29 | 66.3 |
2024-06-05 | 69.4 | 2024-03-28 | 66.3 |
2024-06-04 | 72.8 | 2024-03-27 | 67.5 |
2024-06-03 | 71.8 | 2024-03-26 | 69.0 |
2024-05-31 | 71.4 | 2024-03-25 | 69.0 |
2024-05-30 | 72.1 | 2024-03-22 | 69.2 |
2024-05-29 | 71.9 | 2024-03-21 | 69.5 |
2024-05-28 | 71.0 | 2024-03-20 | 69.9 |
2024-05-27 | 74.2 | 2024-03-19 | 69.7 |
2024-05-24 | 71.4 | 2024-03-18 | 71.4 |
2024-05-23 | 69.8 | 2024-03-15 | 70.7 |
2024-05-22 | 66.2 | 2024-03-14 | 71.4 |
2024-05-21 | 63.3 | 2024-03-13 | 71.6 |
2024-05-20 | 61.4 | 2024-03-12 | 71.3 |
2024-05-17 | 63.5 | 2024-03-11 | 71.5 |
2024-05-16 | 65.2 | 2024-03-08 | 66.3 |
2024-05-14 | 63.3 | 2024-03-07 | 67.5 |
2024-05-13 | 61.4 | 2024-03-06 | 68.6 |
2024-05-10 | 61.9 | 2024-03-05 | 67.5 |
2024-05-09 | 59.8 | 2024-03-04 | 68.2 |
2024-05-08 | 60.2 | 2024-02-29 | 67.9 |
2024-05-07 | 60.8 | 2024-02-28 | 67.0 |
2024-05-03 | 61.3 | 2024-02-27 | 69.0 |
2024-05-02 | 61.3 | 2024-02-26 | 72.2 |
2024-04-30 | 61.0 | 2024-02-23 | 73.2 |
2024-04-29 | 60.4 | 2024-02-22 | 72.2 |
2024-04-26 | 59.8 | 2024-02-21 | 72.0 |
2024-04-25 | 59.7 | 2024-02-20 | 76.8 |
2024-04-24 | 60.2 | 2024-02-19 | 78.7 |
2024-04-23 | 59.6 | 2024-02-16 | 69.8 |
2024-04-22 | 60.3 | 2024-02-15 | 69.1 |
2024-04-19 | 60.6 | 2024-02-14 | 68.9 |
2024-04-18 | 62.4 | 2024-02-13 | 67.1 |
2024-04-17 | 62.3 | 2024-02-08 | 66.3 |
2024-04-16 | 63.0 | 2024-02-07 | 66.2 |
2024-04-15 | 62.2 | 2024-02-06 | 68.7 |
U2Bio Co Ltd (XKRX:221800) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
U2Bio Co Ltd
ISIN : KR7221800006
Compare
Compare
Traded in other countries / regions
221800.Korea IPO Date
2015-06-29Description
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.